Contraline Company

Contraline is a medical device company that has developed a proprietary injectable hydrogel platform for use in reproductive and contraceptive applications. Contraline's first product, Adam, is implanted into the vas deferens through a minimally invasive, outpatient procedure and once implanted, the gel effectively blocks sperm. Adam is non-hormonal, designed to last years, and easily reversible.
Technology: United States
Industry: Reproductive Health & Contraception
Headquarters: Charlottesville, Virginia, United States
Founded Date: 2015-05-20
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 32
Total Funding: $24,630,000
Estimated Revenue: $1M to $10M
Last Funding Date: 2022-11-10
Last Funding Type: Series A

Visit Website
Register and Claim Ownership